Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18

Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age

Published:2012-03 Issue:15 Volume:30 Page:2556-2563
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Halperin Scott A.,Ward Brian,Cooper Curtis,Predy Gerald,Diaz-Mitoma Francisco,Dionne Marc,Embree Joanne,McGeer Allison,Zickler Paul,Moltz Karl-Heinz,Martz René,Meyer Ingo,McNeil Shelly,Langley Joanne M.,Martins Eduardo,Heyward William L.,Martin J. Tyler

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference40 articles.

1. Hepatitis B virus infection;Lee;N Engl J Med,1997

2. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state;McMahon;J Infect Dis,1985

3. Global status of hepatitis B immunisation;Kane;Lancet,1996

4. The global impact of vaccination against hepatitis B: a historical overview;Zanetti;Vaccine,2008

5. Global epidemiology of hepatitis B virus;Custer;J Clin Gastroenterol,2004

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents;Vaccine;2024-10

2. Non‐coding RNAs to treat vascular smooth muscle cell dysfunction;British Journal of Pharmacology;2024-05-21

3. Adjuvants in COVID-19 vaccines: innocent bystanders or culpable abettors for stirring up COVID-heart syndrome;Therapeutic Advances in Vaccines and Immunotherapy;2024-01

4. Development of a new vaccine at the laboratory scale;Bioreactor Design Concepts for Viral Vaccine Production;2024

5. Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses;Expert Review of Vaccines;2023-12-14